Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma. [electronic resource]
Producer: 20100906Description: e426; author reply e427-8 p. digitalISSN:- 1527-7755
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- antagonists & inhibitors
- Clinical Trials as Topic
- Depsipeptides -- pharmacology
- Disease-Free Survival
- Drug Interactions
- Histone Deacetylase Inhibitors -- pharmacology
- Humans
- Hydroxamic Acids -- pharmacology
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Rituximab
- Vorinostat
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.